Diabetic vitreous hemorrhage is linked to neuropathologic changes in specific brain regions, as identified by voxel-based ...

Roche’s Susvimo, a refillable eye implant for diabetic macular edema, provides continuous delivery of ranibizumab, showing ...

The following is a summary of “Evaluation of macular retinal oximetry across different levels of diabetic retinopathy: a cross sectional study,” published in the January 2025 issue of Ophthalmology by ...

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the US Food and Drug Administration (FDA) has approved Susvimo® (ranibizumab injection) 100 mg/mL for the treatment of diabetic macular edema ...

Good (HDL) cholesterol may raise glaucoma risk, while ‘bad’ (LDL) cholesterol could lower the risk of vision loss from ...

OT asked the experts what delegates can expect to hear in clinical imaging, from skills development to applications of the ...

Results from a case series identified a potential association between ophthalmic complications and the rapid correction of hyperglycemia, brought on by patients using either semaglutide or tirzepatide ...

GREENFIELD — An eight-week discipleship experience for young men is coming to Brandywine Community Church.

The condition appears to be triggered when the optic nerve swells, choking off its blood supply because the nerve's pathway ...

The World Health Organization reports that around 2.2 billion people struggle with vision problems such as near-sightedness ...

The new indication adds to the 2021 approval of Susvimo (ranibizumab) for 'wet' or neovascular age-related macular ...

REGN reports better-than-expected Q4 results. However, lead drug Eylea sales decline in the United States due to competition.